Mapping Disease Pathways for Biliary Atresia

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT03273049
Status
Recruiting
Apply to this trial

Conditions

  • Biliary Atresia

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This project will primarily evaluate the developmental/genetic basis of biliary atresia, the most common cause of liver failure at birth, and which accounts of half of all liver transplants performed worldwide in children.

Key Dates

Start date
Jul 21, 2016
Status verified
Sep 2025
Primary completion
Dec 21, 2030
Completion
Jul 21, 2035

Study Design

Enrollment
1,100 participants (estimated)

Primary Outcome Measure

Genomic pathways of BA [ Time Frame: up to two years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UPMC Children's Hospital of PittsburghPittsburghPennsylvania15224
Morgan L Paul, BSN
[email protected]
412-692-8472
Daniel Pieratt, MPA
[email protected]
4126926692
Rakesh Sindhi, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

By research site
UPMC Children's Hospital of Pittsburgh· Pittsburgh, PA

Related Studies